Bowery Clinic expands physician-led selank program for US patients
The telehealth clinic's own overview concedes selank is not FDA-approved and that its evidence base is mostly Russian preclinical work and small trials.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 4 11:10 ETSource: rutlandherald.com
The wire
- 01Bowery Clinic said it expanded its selank program for eligible US patients, publishing an overview of the tuftsin-derived heptapeptide TKPRPGP marketed for stress, anxiety and cognitive support.
- 02Selank has no FDA approval; the clinic notes its removal from the FDA Category 2 list reflected a withdrawn bulk substance nomination, not clearance for compounding.
- 03Cited human data are limited to studies of 62 and 60 patients comparing selank with medazepam and phenazepam; the item is a company release, not independent evidence.
From the source
Read at rutlandherald.comBowery Clinic Expands Physician-Guided Peptide Program With In-Depth Look at Selank, a Synthetic Peptide Studied for Stress, Anxiety, and Cognitive Support
Bowery Clinic Expands Physician-Guided Peptide Program With In-Depth Look at Selank, a Synthetic Peptide Studied for Stress, Anxiety, and Cognitive Support / Source: Bowery Clinic